Cited by 66Platelet Disorders and TreatmentsBlood Coagulation and Thrombosis MechanismsAntiplatelet Therapy and Cardiovascular Diseases

Altered functions of platelets during aging

Open access
Montenont, Emilie, Rondina, Matthew T., Campbell, Robert A.·2019·Current Opinion in Hematology

Abstract

Purpose of review: Platelets are specialized effector cells that rapidly respond to sites of vascular injury. However, emerging data demonstrate that platelets possess diverse functions that also mediate inflammatory responses and neurological diseases. These functions are relevant to disease processes prevalent among older adults and likely influence susceptibility to thrombotic and inflammatory disorders. Recent findings: Platelet counts decrease in aged individuals whereas platelet reactivity increases. The platelet transcriptome is altered in aged individuals resulting in altered platelet function and exaggerated inflammation. Platelet signaling to monocytes in aging results in significantly more cytokines because of increased platelet-derived granzyme A. Platelet activation in aging appears to be driven, in part, because of increased reactive oxygen species and activation of the mammalian target of rapamycin pathway. Increased platelet hyperactivity in diseases is associated with aging, such cardiovascular disease and sepsis, exaggerate inflammation and thrombosis. Noncanonical functions of platelets influence the development of neurological diseases including Alzheimer's disease. Summary: Although there have been advances dissecting the molecular mechanisms regarding aging-related changes in platelets, many knowledge gaps still remain. Studies filling these gaps are likely to identify new mechanisms driving aging-related changes in platelet gene expression and function, and contributing to injurious thrombo-inflammation in older adults.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/moh.0000000000000526

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Platelets, which are responsible for approximately 90% of circulating amyloid-β, are overactivated with ageing and release more amyloid-β, subsequently inducing amyloid-β deposition in the brain and cognitive impairment.

    “Platelets, which are responsible for approximately 90% of circulating Aβ,313 are overactivated with ageing314,315 and are reported to release more Aβ and subsequently induce Aβ deposition in the brain and cognitive impairment.316”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [49]Reny JL, Fontana P, Hochholzer W, Neumann FJ, Ten Berg J, Janssen PW, Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data. Thromb Haemost. 2016; 115(4): 844– 55. 26607655

Cited by

Sorted by citations

Authors
Montenont, E., Rondina, M. T., & Campbell, R. A.
Affiliations
University of Utah (US)
Corresponding author
Campbell, Robert A.
Venue
Current Opinion in Hematology
Published
2019-09
Volume
26
Issue
5
Pages
336-342
ISSN
  • 1065-6251 (ISSN-L)
  • 1531-7048
OpenAlex
W2957922577
Cited by
66
References
64
Citations by year
2026: 14 · 2025: 7 · 2024: 12 · 2023: 10 · 2022: 10 · 2021: 5 · 2020: 8
FWCI
0.92
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Hematology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Veterans Affairs (I01 CX001696)
  • National Institutes of Health (UL1TR002538)
  • National Institute on Aging (R01AG048022, K01AG059892, R56AG059877)
  • National Heart, Lung, and Blood Institute (R01HL142804, R01HL126547)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords
platelets, aging, platelet hyperreactivity, platelet transcriptome, reactive oxygen species, mTOR signaling, thromboinflammation, thrombosis, inflammation, Alzheimer's disease, cardiovascular disease, sepsis, older adults
MeSH terms
Aging, Blood Platelets, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review